Best Veeva Vault CRM Alternatives (2026)

Why look for a Veeva Vault CRM alternative

Let's be clear up front: Veeva is dominant in life-sciences CRM for good reasons. It was built specifically for pharma field reps, HCP and HCO engagement, closed-loop marketing, sample management, and the compliance reality of selling regulated products. For a global biopharma field force, that depth is hard to match, and most large pharma will stay.

So why are teams evaluating alternatives in 2026? A few real reasons:

• Cost. Veeva is a premium, enterprise-priced platform. For a 10- or 30-person commercial team at a biotech, medtech, or diagnostics company, the per-seat economics can be hard to justify against what the team actually uses.
• Heaviness. Veeva is engineered for large, pharma-specific field operations. Smaller commercial teams frequently find it's overkill — more process, configuration, and compliance machinery than their go-to-market actually needs.
• The Salesforce-to-Vault migration. Veeva moved its CRM off the Salesforce platform onto its own Vault platform. Every Veeva customer faces a re-platforming and re-validation project on that timeline whether they like it or not. When you're already absorbing that disruption, it's a natural moment to ask whether you're on the right platform at all.
• A desire for something more general or affordable. Companies whose commercial motion isn't purely field-rep-and-HCP — or who want one platform across sales, marketing, and support — often want a more general CRM they can shape to fit.

If any of those describe you, the picks below are worth a look. The honest framing: none of them is a pre-validated, drop-in Veeva replacement for a regulated field force. Choose by team size and how much pharma-specific compliance you genuinely need.

How we picked

We weighted four things for a life-sciences buyer: how directly the platform maps to field, medical, and HCP-engagement use cases; how much compliance and regulated-data handling it can support (natively or via partners); cost relative to Veeva; and fit by team size, since a 500-rep biopharma and a 15-person diagnostics launch team need very different things. We were deliberately honest about where each option needs configuration or a partner to approach what Veeva ships out of the box.

Salesforce — the most direct enterprise alternative

Salesforce is the obvious starting point, and not by accident: Veeva CRM was originally built on the Salesforce platform before Veeva moved to Vault. Salesforce's own Life Sciences Cloud targets the same territory — field engagement, medical, HCP/HCO relationship management, and connected commercial data. For a large pharma or biopharma that wants enterprise scale, a vast partner ecosystem, and AI/automation depth, it's the most credible like-for-like alternative. The trade-offs are familiar: enterprise pricing in Veeva's neighborhood, and you'll lean on a specialized life-sciences implementation partner to build and validate the pharma-specific workflows Veeva delivers as product. Best for enterprise teams that want to stay on a Salesforce-class platform without Veeva.

Creatio — mid-market with no-code compliance workflows

Creatio's strength is a no-code platform that lets you model complex, regulated processes without a heavy development team. For a mid-market life-sciences organization — a growing biotech or a medtech with a real but not massive field force — that flexibility matters: you can build HCP engagement flows, approvals, and audit-friendly processes visually and adapt them as the business changes. It won't arrive pre-loaded with Veeva's validated pharma modules, but its workflow engine and BPM roots make it well-suited to encoding compliance logic yourself. Best for mid-market teams that want enterprise-grade process control without enterprise-grade cost or rigidity.

SugarCRM — configurable mid-market platform

SugarCRM is a mature, highly configurable CRM that fits commercial life-sciences teams that need a solid sales and account platform but don't require Veeva's full pharma-validation stack. It offers strong customization, on-premise or cloud deployment options (useful when data-residency or control matters), and predictable pricing. Think of it as a capable general CRM you shape to your commercial process — territory and account management, pipeline, and customer engagement — rather than a purpose-built HCP-compliance system. Best for mid-market commercial teams that value configurability and deployment flexibility over industry-specific modules.

Zoho CRM — best value for cost-sensitive small commercial teams

For small biotech, medtech, and diagnostics teams watching every dollar, Zoho CRM is the value leader. It's deeply customizable, integrates with a broad suite of business apps, and costs a fraction of an enterprise life-sciences platform. A small field or commercial team can model accounts, contacts, and territories, and automate the basics, without an enterprise budget. The caveats are honest ones: regulated HCP data handling, Part 11-style controls, and validation are on you and your implementation partner. For a lean team that needs a real CRM — not a validated pharma field system — that's an acceptable trade. Best for cost-sensitive small commercial and field teams.

HubSpot — best for early biotech and diagnostics commercial launch

HubSpot shines when a company is standing up its first commercial motion. An early-stage biotech approaching launch, or a diagnostics company building out sales and marketing, gets a clean, fast-to-deploy platform that unifies CRM, marketing, and customer engagement — and it starts free. The appeal is speed and simplicity: a small team can be productive in days, not a quarter. As with the other general CRMs, it isn't a pharma-validated environment; you'll configure compliance and likely bring in a partner as you scale into regulated HCP territory. Best for early-stage life-sciences companies launching a commercial team for the first time.

How to choose

Anchor the decision on two questions: how big is the team, and how much pharma-specific compliance do you truly need?

• Enterprise field force, staying on a Salesforce-class platform → Salesforce (Life Sciences Cloud) with a life-sciences partner.
• Mid-market, process-heavy, wants to own its compliance workflows → Creatio.
• Mid-market commercial team, configurability and deployment control → SugarCRM.
• Small, cost-sensitive commercial or field team → Zoho CRM.
• Early-stage launch, first commercial motion → HubSpot.

A note on compliance and validation

This is where intellectual honesty matters most. Veeva's durable advantage is that it ships validated, life-sciences-specific functionality: HCP/HCO data models, consent and sample management, closed-loop marketing, audit trails, and an environment built around 21 CFR Part 11 and GxP expectations. None of the alternatives here arrive that way. They are general (or general-purpose-with-BPM) platforms that can be configured to meet many regulated requirements — but the validation, e-signature and audit controls, and HCP data governance become your responsibility, usually with a specialized implementation partner. For a small commercial team, that's a manageable scope. For a large regulated field-force operation, it's a serious program of work you should budget and staff for deliberately. Don't let a lower sticker price hide the validation cost.

The bottom line

Veeva earned its dominance, and for global biopharma it will keep it. But the cost, the heaviness for smaller teams, and the unavoidable disruption of the Salesforce-to-Vault migration make 2026 a fair moment to re-evaluate. If you want an enterprise platform without Veeva, Salesforce is the most direct path. For mid-market, weigh Creatio for workflow and compliance control or SugarCRM for configurability. For small and early-stage commercial teams, Zoho CRM delivers the best value and HubSpot the fastest launch. Just go in clear-eyed: you're trading Veeva's pre-validated, pharma-specific depth for lower cost and flexibility — and the compliance work that depth represented doesn't disappear, it moves to you.